NextEra Energy recorded a big jump in profit for the second quarter from climbing revenue and a decline in costs. The clean-energy company posted a profit of $3.14 billion, or $1.50 a share, up from ...
Shares of Outlook Therapeutics posted wide swings as the Food and Drug Administration approved the company's Lytenava for treatment of neovascular age-related macular degeneration.
A group including the Japan Agency for Marine-Earth Science and Technology (JAMSTEC) on Friday announced that the majority of rare earth elements retrieved from sediment collected from the seabed off ...
The Japan Aerospace Exploration Agency (JAXA) on Thursday conducted a ground combustion test of a second-stage engine for the Epsilon S small solid-fuel rocket that it is currently developing.